01 April 2004
Dietary supplementation with olive oil leads to improved lipoprotein spectrum and lower n-6 PUFAs in elderly subjects
Peter Haban, Jana Klvanova, Eva Zidekova, Anna NagyovaMed Sci Monit 2004; 10(4): PI49-54 :: ID: 11621
Abstract
Background:Oleic acid, polyphenols, and other components abundantly present in olive oil are thought to be partly responsible for the antiatherogenic effects attributed to the Mediterranean diet. One of the expected outcomes is a positive impact on the lipoprotein spectrum, but also other benefits are to be expected.Material/Methods: The analysis was conducted on 28 outpatients older than 50 years of age (mean age 68.1, 95%CI 64.9–71.3). The supplement was taken for 6 weeks and involved daily consumption of 2 tablespoons (approx. 20 g) of extra-virgin olive oil as part of the subjects’ habitual diets, without changing their usual total energy and fat consumption. This phase was followed by a 2-month wash-out.Results: After dietary supplementation with olive oil, serum total- and LDL-cholesterol mean concentrations were lowered by 0.818 mmol/l (p<0.00002; 95% CI –1.142 to –0.493 mmol/l) and 0.782 mmol/l (p=0.00013; 95% CI –1.141 to –0.423 mmol/l), respectively. There was also a significant decline in the total-to-HDL and LDL-to-HDL cholesterol ratios (p<0.03 and p<0.015). Linolic and arachidonic acid content in serum phospholipids decreased significantly (p<0.01 and p<0.001, respectively). The n-3 PUFAs were not affected.
Conclusions: These results point to an overwhelmingly beneficial influence of olive oil on the lipoprotein spectrum. The statistically significant reduction in arachidonic acid may even be regarded as clinically desirable. An excellent complementarity between the effects of MUFAs and long-chain n-3 PUFAs is to be expected.
Keywords: Arachidonic Acid, Cholesterol - blood, Dietary Supplements, Fatty Acids, Unsaturated - blood, Hypercholesterolemia - blood, Hypercholesterolemia - diet therapy, Lipids - blood, Oleic Acid - pharmacology, Plant Oils - pharmacology, Triglycerides - blood, Arachidonic Acid, Cholesterol - blood, Dietary Supplements, Fatty Acids, Unsaturated - blood, Hypercholesterolemia - diet therapy, Lipids - blood, Oleic Acid - pharmacology, Plant Oils - pharmacology, Triglycerides - blood
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952